Foghorn Therapeutics, Inc. (FHTX)
1.96
-0.09
(-4.39%)
USD |
NASDAQ |
Nov 13, 10:17
Foghorn Therapeutics Free Cash Flow (Quarterly) : -18.25M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -18.25M |
| June 30, 2026 | -17.89M |
| March 31, 2026 | -25.27M |
| December 31, 2025 | -22.27M |
| September 30, 2025 | -18.86M |
| June 30, 2025 | -21.02M |
| March 31, 2025 | -24.00M |
| December 31, 2024 | -25.00M |
| September 30, 2024 | -21.31M |
| June 30, 2024 | -25.55M |
| March 31, 2024 | -29.45M |
| December 31, 2023 | -27.58M |
| September 30, 2023 | -27.29M |
| June 30, 2023 | -32.64M |
| Date | Value |
|---|---|
| March 31, 2023 | -31.82M |
| December 31, 2022 | -29.19M |
| September 30, 2022 | -20.32M |
| June 30, 2022 | -29.38M |
| March 31, 2022 | 271.29M |
| December 31, 2021 | 11.80M |
| September 30, 2021 | -20.73M |
| June 30, 2021 | -19.69M |
| March 31, 2021 | -24.94M |
| December 31, 2020 | -18.14M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -11.78M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | -9.096M |
| Vaxcyte, Inc. | -229.04M |
| Connect Biopharma Holdings Ltd. | -16.19M |
| Caribou Biosciences, Inc. | -22.54M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |